Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis
AnnaLynn M. Williams(University of Rochester), Michelle C. Janelsins(University of Rochester), Carly Paterson Khan(Patient-Centered Outcomes Research Institute), Mary Ontko(Dayton Clinical Oncology Program), Luke J. Peppone(University of Rochester Medical Center), Debra L. Barton(University of Michigan), Charles Kamen(University of Rochester), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Jodi Geer(Metro-Minnesota Community Oncology Research Consortium), Shaker R. Dakhil(Cancer Center of Kansas), Victor Kipnis(National Cancer Institute), Amber S. Kleckner(University of Maryland, Baltimore), Ann M. O’Mara(National Cancer Institute), Jerry W. Mitchell(Seagen (Canada))
Cited by 91
Related Papers
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913